routinely measured in echocardiographic or catheterization laboratories for calculation of cardiac output and AVA. As reported previously (1, [3] [4] [5] [6] [7] [8] 10, 11) and corroborated by Tribouilloy et al. (14) , 30% to 50% of aortic stenosis patients with preserved LVEF have LF (SVi <35 ml/m 2 ). This is not necessarily surprising, because the aortic stenosis population is predominantly elderly, with frequent comorbidities (e.g., hypertension, coronary artery disease, atrial fibrillation, pronounced LV concentric hypertrophy, LG on outcomes difficult to delineate. In univariable analysis, mortality at 2 years was 2-fold higher in the LF/LG group than in the other 3 groups (Table 1) 
IMPACT OF AVR ON OUTCOMES OF PATIENTS WITH PARADOXICAL LF/LG
Does AVR improve outcomes in patients with LF/LG aortic stenosis? The majority of studies have shown that AVR is associated with significant survival benefit in these patients (Table 1 ) (4-7,9,11-13,17), whereas Tribouilloy et al. (14) reported no benefit.
However, very few (<10) patients in the LF/LG group underwent AVR, and with such limited statistical power, it is difficult to draw a definitive conclusion. In addition, 61% of the HG severe aortic stenosis group were symptomatic at baseline, and thus, had a class I indication for AVR (14). Further studies are needed to determine which patients with paradoxical LF/LG aortic stenosis would benefit from AVR and which type of AVR (surgical vs.
transcatheter) should be used.
MANAGEMENT OF PATIENTS WITH PARADOXICAL LF/LG
When confronted with a patient with a small AVA The following algorithm for clinical decision-making addresses these key criteria. 
